作者
Sophia E Schröeder, Alisa Pedrana, Nick Scott, David Wilson, Christian Kuschel, Lisa Aufegger, Rifat Atun, Ricardo Baptista‐Leite, Maia Butsashvili, Manal El‐Sayed, Aneley Getahun, Saeed Hamid, Radi Hammad, Ellen ‘t Hoen, Sharon J Hutchinson, Jeffrey V Lazarus, Olufunmilayo Lesi, Wangsheng Li, Rosmawati Binti Mohamed, Sigurdur Olafsson, Raquel Peck, Annette H Sohn, Mark Sonderup, Catherine W Spearman, Tracy Swan, Mark Thursz, Tim Walker, Margaret Hellard, Jessica Howell
发表日期
2019/10
来源
Liver International
卷号
39
期号
10
页码范围
1818-1836
简介
Viral hepatitis is a leading cause of morbidity and mortality worldwide, but has long been neglected by national and international policymakers. Recent modelling studies suggest that investing in the global elimination of viral hepatitis is feasible and cost‐effective. In 2016, all 194 member states of the World Health Organization endorsed the goal to eliminate viral hepatitis as a public health threat by 2030, but complex systemic and social realities hamper implementation efforts. This paper presents eight case studies from a diverse range of countries that have invested in responses to viral hepatitis and adopted innovative approaches to tackle their respective epidemics. Based on an investment framework developed to build a global investment case for the elimination of viral hepatitis by 2030, national activities and key enablers are highlighted that showcase the feasibility and impact of concerted hepatitis …
学术搜索中的文章
SE Schröeder, A Pedrana, N Scott, D Wilson… - Liver International, 2019